2. Apoptosis
  3. Apoptosis
  4. 13-Methyltetradecanoic acid

13-Methyltetradecanoic acid  (Synonyms: 13-MTD; 13-Methylmyristic acid)

製品番号: HY-131503 純度: 99.97%
COA 取扱説明書 Technical Support

13-Methyltetradecanoic acid (13-MTD), a saturated branched-chain fatty acid with potent anticancer effects. 13-Methyltetradecanoic acid induces apoptosis in many types of human cancer cells.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

13-Methyltetradecanoic acid

13-Methyltetradecanoic acid 構造式

CAS 番号 : 2485-71-4

容量 価格（税別） 在庫状況 数量
Solution
10 mM * 1 mL in Ethanol USD 110 在庫あり
Solid
5 mg $100 在庫あり
10 mg $170 在庫あり
25 mg $300 在庫あり
50 mg $500 在庫あり
100 mg $850 在庫あり
200 mg   お問い合わせ  
500 mg   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 0 publication(s) in Google Scholar

Other Forms of 13-Methyltetradecanoic acid:

13-Methyltetradecanoic acid 関連抗体

Top Publications Citing Use of Products

  • 生物活性

  • 純度とドキュメンテーション

  • 参考文献

  • カスタマーレビュー

製品説明

13-Methyltetradecanoic acid (13-MTD), a saturated branched-chain fatty acid with potent anticancer effects. 13-Methyltetradecanoic acid induces apoptosis in many types of human cancer cells[1][2].

体外実験

13-Methyltetradecanoic acid (13-MTD; 0-140 μg/mL; 12-24 hours) inhibits cell viability and proliferation in human bladder cancer cells by inducing apoptosis[1].
13-Methyltetradecanoic acid (13-MTD; 70 μg/mL; 2-48 hours) treatments results in significant accumulation of cells with sub-G1 DNA content in a time-dependent manner, with the proportion of sub-G1 phase DNA content ranging from 9.25% to 85.3% over 2-48 hours[1].
13-Methyltetradecanoic acid (13-MTD; 70 μg/mL; 2-24 hours) down-regulates Bcl-2 and up-regulates Bax. This promotes mitochondrial dysfunction, leading to the release of cytochrome c from the mitochondria to the cytoplasm, as well as the proteolytic activation of caspases. 13-Methyltetradecanoic acid down-regulates AKT phosphorylation and activates phosphorylation of p38 and c-Jun N-terminal kinase (JNK)[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

13-Methyltetradecanoic acid 関連抗体

Cell Viability Assay[1]

Cell Line: Bladder cancer cell lines T24, 5637, and UM-UC-3
Concentration: 0 μg/mL, 35 μg/mL, 70 μg/mL, 105 μg/mL, and 140 μg/mL
Incubation Time: 12 hours, 24 hours
Result: Inhibition of cell viability in a dose- and time-dependent manner.

Cell Cycle Analysis[1]

Cell Line: Bladder cancer cell lines T24, 5637, and UM-UC-3
Concentration: 70 μg/mL
Incubation Time: 2 hours, 8 hours, 24 hours, or 48 hours
Result: Resulted in significant accumulation of cells with sub-G1 DNA content in a time-dependent manner.

Western Blot Analysis[1]

Cell Line: T24, 5637, and UM-UC-3 cells
Concentration: 70 μg/mL
Incubation Time: 2 hours, 8 hours, 24 hours
Result: Down-regulated Bcl-2 and up-regulated Bax, and down-regulated AKT phosphorylation and activated phosphorylation of p38 and c-Jun N-terminal kinase (JNK).
体内実験

13-Methyltetradecanoic acid (13-MTD; 70 mg/kg/day; oral gavage; daily; for 30 days) significantly suppresses tumor growth in a xenograft model[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: BALB/C nude mice injected with Jurkat lymphoma cells[2]
Dosage: 70 mg/kg/day
Administration: Oral gavage; daily; for 30 days
Result: Effectively inhibited the growth in vivo in a xenograft model.
分子量

242.40

分子式

C15H30O2
CAS 番号
Appearance

Solid

Color

White to off-white

SMILES

CC(C)CCCCCCCCCCCC(O)=O
Structure Classification
Initial Source
輸送条件

Room temperature in continental US; may vary elsewhere.
保管条件
Powder -20°C 3 years
In solvent -80°C 6 months
  -20°C 1 month
溶剤 & 溶解度
体外: 

Ethanol : ≥ 100 mg/mL (412.54 mM)

*"≥" means soluble, but saturation unknown.

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 4.1254 mL 20.6271 mL 41.2541 mL
5 mM 0.8251 mL 4.1254 mL 8.2508 mL
10 mM 0.4125 mL 2.0627 mL 4.1254 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます：C1V1 = C2V2

濃度 （開始）

C1

×
体積 （開始）

V1

=
濃度 （終了）

C2

×
体積 （終了）

V2

体内:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  10% EtOH    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 2.5 mg/mL (10.31 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL EtOH stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

    Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
  • Protocol 2

    Add each solvent one by one:  10% EtOH    90% (20% SBE-β-CD in Saline)

    Solubility: ≥ 2.5 mg/mL (10.31 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL EtOH stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

    Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
純度とドキュメンテーション

純度: 99.97%

COA (238 KB) HNMR (243 KB) RP-HPLC (245 KB)

取扱説明書 (2659 KB)
参考文献

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
Ethanol 1 mM 4.1254 mL 20.6271 mL 41.2541 mL 103.1353 mL
5 mM 0.8251 mL 4.1254 mL 8.2508 mL 20.6271 mL
10 mM 0.4125 mL 2.0627 mL 4.1254 mL 10.3135 mL
15 mM 0.2750 mL 1.3751 mL 2.7503 mL 6.8757 mL
20 mM 0.2063 mL 1.0314 mL 2.0627 mL 5.1568 mL
25 mM 0.1650 mL 0.8251 mL 1.6502 mL 4.1254 mL
30 mM 0.1375 mL 0.6876 mL 1.3751 mL 3.4378 mL
40 mM 0.1031 mL 0.5157 mL 1.0314 mL 2.5784 mL
50 mM 0.0825 mL 0.4125 mL 0.8251 mL 2.0627 mL
60 mM 0.0688 mL 0.3438 mL 0.6876 mL 1.7189 mL
80 mM 0.0516 mL 0.2578 mL 0.5157 mL 1.2892 mL
100 mM 0.0413 mL 0.2063 mL 0.4125 mL 1.0314 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

13-Methyltetradecanoic acid Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質量   濃度   体積   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます：C1V1 = C2V2

濃度 （開始） × 体積 （開始） = 濃度 （終了） × 体積 （終了）
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

13-Methyltetradecanoic acid2485-71-413-MTD 13-Methylmyristic acidApoptosisBcl-2Baxcytochrome-cp-p38AKTphosphorylationapoptosissaturatedbranched-chainInhibitorinhibitorinhibit

最近チェックした製品:

オンラインお問い合わせ

Your information is safe with us. * Required Fields.

製品名

  

カスタマ需要量 *

お名前 *

 

タイトル

メールアドレス *

 

電話番号 *

デパートメント

 

組纖名 *

市区町村

都道府県

国或いは地域 *

      

必ず会社名を記載ください。個人への返信は行いません。

備考

バルクお問い合わせ

Inquiry Information

製品名:
13-Methyltetradecanoic acid
製品番号:
HY-131503
数量:
MCE 日本正規代理店:

カスタマーレビュー

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

製品名

  

Lot #

お名前 *

 

メールアドレス *

電話番号 *

 

部門 *

組纖名 *

 

国或いは地域 *

備考

Request for HNMR Report

We have received your request and will respond to you as soon as possible.